A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers.
Wang M, Ferreira RB, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Sharma A, Avery BA, Rodriguez E, Chiang CW, Narayan S, Heldermon CD, Castellano RK, Law BK.
Wang M, et al. Among authors: heldermon cd.
Oncogene. 2019 May;38(22):4264-4282. doi: 10.1038/s41388-019-0717-6. Epub 2019 Feb 4.
Oncogene. 2019.
PMID: 30718919